Does PDRN (salmon DNA) skincare actually work?

Short answer: the strongest evidence for PDRN — a 2026 systematic review of 7 randomized trials — comes almost entirely from injections and wound care, not the serums and creams sold as "salmon DNA" skincare. It found real, modest benefits for wrinkles, scars, and healing, but the review's own authors call the evidence base small and inconsistent. Topical PDRN specifically has almost no human trial data at all.

What is PDRN, and why is it called "salmon DNA"?

PDRN stands for polydeoxyribonucleotide — short fragments of DNA, most commonly purified from salmon or trout milt, which is the source of the "salmon DNA" branding. On a cosmetic ingredient list, the same material is usually labeled with its INCI name, Sodium DNA. In clinics, PDRN is injected as a "skin booster" alongside treatments like microneedling; in skincare aisles, it's formulated into serums, ampoules, and moisturizers marketed on the same premise — that DNA fragments can signal skin cells to heal and regenerate.

What does the actual clinical evidence say?

The most rigorous evidence available is a 2026 systematic review published in Cureus, led by researchers at Almaarefa University in Saudi Arabia with co-authors from several other Saudi academic institutions [1]. It pooled 7 randomized controlled trials — 4 on skin rejuvenation, 1 on postoperative scar prevention, 2 on wound healing — covering 183 participants total. Across those trials, PN/PDRN treatments improved wrinkle-related outcomes, scar quality, wound-healing metrics, and patient-reported satisfaction compared with controls, with no serious adverse events reported [1].

The strongest, most consistent signal was in wound healing, where PDRN sped up re-epithelialization and shortened healing time [1] — a very different use case from an anti-aging serum. The authors are explicit that the overall evidence base is still small, with heterogeneous protocols and outcome measures across the seven trials, and they call for larger, more standardized studies before treating the findings as settled [1]. We reached the abstract and record-level detail on this review through EuropePMC rather than the publisher's full-text page, which is not open access; we could not independently confirm a funding or conflict-of-interest statement for the paper, so treat that specific question as unresolved rather than clean.

Does any of that apply to the cream you'd actually buy?

Mostly, no — and this is the gap the "salmon DNA skincare" marketing tends to skip over. The 2026 review's seven trials are concentrated in injectable and wound-dressing contexts, delivered by a clinician or under occlusion, not spread on skin as a leave-on cosmetic [1]. Injecting a compound past the skin barrier and applying it topically are not interchangeable — the skin barrier is specifically built to keep large molecules like DNA fragments from penetrating deep into skin, so a formula that works as an injection doesn't automatically work the same way in a jar.

Two more targeted studies look at topical PDRN formulas directly, and both come with real caveats. A 2025 study out of Gachon University in Korea, funded by a South Korean government innovation grant rather than a cosmetics company, tested a topical polynucleotide mixture against UV-triggered skin pigmentation — but the work was done in cultured skin cells and in mice, not human skin, and measured pigmentation pathways rather than wrinkles or "glow" [2]. A 2024 study from Asan Medical Center in Seoul tested a topical PDRN-hyaluronic-acid hydrogel on barrier recovery after tape-stripping — also in mice, not humans — and found it sped up trans-epidermal water loss recovery versus untreated skin [3]; worth flagging plainly, two of that paper's authors are affiliated with BRPHARM Co., a Korean company that manufactures PDRN-based products, a direct commercial tie to the ingredient being tested [3]. Between the two, that's one government-funded animal study and one company-linked animal study — real data, but neither is a human trial of a topical product, and citing them as proof a $20–30 serum "works" overstates what either one actually measured.

Is it safe to try anyway?

Nothing in the sources here flags PDRN skincare as unsafe at typical topical concentrations — the injectable trials reported no serious adverse events [1], and PDRN is a molecule the body already recognizes (it's DNA, broken into fragments). But "no red flags in the injectable literature" isn't the same as "proven to do something on skin." If you're drawn to a PDRN cream or serum, it's reasonable to treat it the way you'd treat any unproven-but-plausible humectant or barrier-support product: patch test first (see our guide on introducing a new active), and don't expect injectable-level "skin booster" results from a leave-on formula.

What about a specific product, like Genabelle's PDRN cream?

Genabelle's PDRN Rejuvenating Cream (2.36 fl. oz., listed at $28.00 at the time of writing) is one of the catalog's PDRN options and carries a retailer-reported rating of 4.8 out of 5 from 598 reviews on Olive Young — a retailer star rating, not an independent clinical measurement, and worth reading as social proof rather than evidence of efficacy. Given everything above, that's the honest frame for any PDRN cream: a plausible, generally low-risk moisturizing ingredient riding a genuine K-beauty trend wave, not a product with its own human trial behind it. If barrier support and hydration are what you're after, the underlying evidence for that job is stronger elsewhere — see our breakdown of peptides in skincare or the honest read on another hyped K-beauty active in snail mucin, evaluated — while a PDRN product itself is worth trying mainly if the price and packaging appeal to you, not because the topical science is settled.

The bottom line

PDRN's injectable and wound-care evidence is real, if modest and still developing. Its topical, over-the-counter evidence is thin — two small animal studies, one with a direct manufacturer tie — years behind the marketing built on the ingredient's clinic-grade reputation. That gap between "well-studied injection" and "trending serum" is common in skincare, and PDRN is a clean current example of it.